Turning Data into Tools to Save Lives - Amazon S3...Dec 01, 2014 · Turning Data into Tools to...
Transcript of Turning Data into Tools to Save Lives - Amazon S3...Dec 01, 2014 · Turning Data into Tools to...
12/1/2014
1
Turning Data into Tools to Save Lives
Frank Myers BA, MA, CIC
Infection Preventionist III
University of California, San Diego Healthcare System
12/1/2014
2
• Data are unactionable
• Data are unrevealing
• Data are stagnant
Data are useless
• Changes minds
• Changes behavior
• Is actionable
• Is fluid
Information
12/1/2014
3
• You need to understand
– What others think
– What motivates behavior change for your audience
The key is changing data into information
• HIV seroprevalence study – (double blinded testing of all syphilis specimens)
• Designed for planning for future AIDS needs in the state
• Study of high and low risk populations– IDU (drug screen)
– STD patients
– Woman giving birth (heel stick for genetic diseases)
An Old Story(1980’s)
12/1/2014
4
• 34% of all patients attending one STD clinic
were HIV +
• A combination of MSM, IDU, and high risk
heterosexual activity
STD clinic data
• More than 1 out of 3 people were HIV+ at the clinic – And by extension the waiting room
• Most people would return to the clinic within 2 years
• I was scared and wanted them to stop putting themselves at risk
• I wanted to motivate a behavior change– They thought their behavior was resulting in only a
trip to the STD clinic
Data to information
12/1/2014
5
• 34% is not a number people understand
• 1 out of 3 is (sort of)
Speaking the Language
• 1 out of every 3 people in this STD clinic
waiting room likely has HIV. Look around. Is
that one you? If not what can you do to
prevent yourself from being in this waiting
room again and being at risk again?
– Returns to the STD clinic went down significantly.
– STDs in the ZIP code it served went down
significantly.
Motivation
12/1/2014
6
• Bias from who completes the form
• If you comply with completing the form you
are more likely to comply with safe CLIP
Who has found anything useful in the CLIP data?
• What percent of central lines inserted in your
ICU are femoral?
– 0-1%
– 2-5%
– 6-8%
– 9-11%
– 11% or more
Vote Time!
12/1/2014
7
CLIP 8.2% of lines inserted in California adult ICUs are femoral lines
• The source of all knowledge is comparative!
Congratulations you turned data into information
12/1/2014
8
Flow of ProcessSSI Outlier identified in
analysis BEFORE Infection
Control Committee (ICC)
meeting
Data goes to Infection
Control Committee (ICC)
Data given to
Medical Director
Investigation into causes for
high SSI rate is done before
next ICC meeting
Data discussed at ICC and
decision to investigate further
reached
Non-standardized
investigations done using
ICC hypothesis
Data and identified issues
shared with surgical group
If theories are incorrect,
investigation results go
back to ICC (?)
Flow of New Process
SSI outlier identified in
analysis before ICC meeting
Analysis done of likely causes
for high rate
Data go to Medical DirectorData go to ICC along with
issues ruled out as causes
Data and identified issues
shared with surgical group
Discussion at ICC about data,
identified issues
12/1/2014
9
� Identify a surgical site outlier�Use SIR and p value assuming an alpha 0.05
� Pick a least a 6 months to a year of data
�Run line listing report to capture all variables which is a interest to you and the providers
Extracting Line Listing from NSHN
Selecting your variables from NSHN
12/1/2014
10
Sorting the Variables
� Use the filter icon in Excel to help you sort your variables
� Filter by infections / No infections
1) Gender
2) Avg. AGE
3) BMI Avg.
4) Scope
5) Average Surgery Time
6) ASA Score
7) Wound Class
12/1/2014
11
Sample of a Line Listing
Line listing from NHSN formula used =(3*60)+K42
patID dob gender proceedProc Date
Proc Code
asaBMI_ val
proc Duration
Hr
Combo
of
hrs/mins
ProcDuratio
nMin
Anes. emerg scopeSw
Class
trauma
Age At
Procinfection
12345678 1/1/00 F 12345678 1/1/00 colo 3 24.5 3 222 42 3 N Y 2 N 32 Y
� Once the line listing is complete
� Sort out your variables
� Infection – No infections
� Female – Males
� Scope – Not Scope
� Avg Procedure time
� BMI average
� ASA score
Sorting the Line Listing
12/1/2014
12
Identifying the variable that can be an value
when analyzing SSI.
EXAMPLES: INFECTION NO INFECTIONS
GENDER Females (10) Males (9) = 19 Females (103) Males (117) =220
Avg. AGE 60 54
AVG SURG.TIME 4.7 hours 3.6 hours
SCOPE 9 Were scoped 129 Not scoped
BMI Average 27.4 25
ASA Score 2.7 2.9
� 88 % of COLO patients in 8 months had no infections
Built in NHSN test
12/1/2014
13
http://www.openepi.com/SMR/SMR.htm
12/1/2014
14
Statistical Test
The following test can help to identify different variables, which can help to recognize
what is significantly expected or not expected.
� Whitney-Mann Test (ordinal data)
� Fisher Exact Test
� T- test independent Sample Test (add this website)
� Website: http://www.real-statistics.com
Whitney-Mann Test
� Whitney- Mann U Test: is a nonparametric test of the null hypothesis that two
populations are the same against an alternative hypothesis, especially that a
particular population tends to have larger values than the other.
Example: ASA Score ( infection & No Infection)
12/1/2014
15
Mann-Whitney U Test
RAW DATA
ASA Infections ASA No Infection
3 3 3 3 3 3 2 3
2 3 3 4 3 3 2 3
2 3 3 4 2 3 2 3
3 3 3 3 3 2 3 2
3 3 3 3 2
2 3 2 2
3 3 3 1
3 4 3 3
3 3 2 3
3 3 5 3
3 4 2 3
3 3 3 2
3 3 2 2
3 3 2 2
3 2 2 2
1 3 2 3
3 2 2 3
3 3 3 3
4 3 3 3
2 3 3 3
4 4 4
Test via normal distribution
ASA infection ASA No Infection
count 17 64
median 3 3
rank sum 51 163
U 1190 3005
α 0.05
tails 1
U 1190
mean 544
variance 7434.7
Example: ASA Score ( infection & No Infection)
Whitney-Mann Test
� Website: http://www.real-statistics.com
KEY = CC 1
Mann-Whitney U Test CO 2
Raw Data D 3
U 4
Wound Class Infections Wound Class No Infection
1 1 1 1 2
1 2 1 2 1
2 1 1 1 3
2 1 1 1 2
2 1 2 1 1
2 3 1 2 1
2 1 1 1 2
2 2 2 2 1
2 1 4 4 1
1 1 2 3 1
1 1 1 1
1 1 2 1
2 2 2 1
3 1 2 1
1 1 1 2
2 2 1 1
1 1 1 1
1 1 1 2
2 2 1 1
1 3 1 1
1 1 3 3
3 3 3 3
Whitney-Mann Test
Example: Wound Class
(infection & No Infection)
Test via normal distribution
Wound Class
infection
Wound Class
No Infection
count 10 88
median 2 1
rank sum 16 138
U 919 4658
α 0.05
tails 1
U 919
mean 440
variance 7260
std dev 85.20563362
z-score 5.621694009
U-crit 299.3492045
p-value 0.999999991
sig no
r 0.567878651
12/1/2014
16
Fisher Exact Test
�Fisher Exact Test : is a statistical significance test used in the
analysis of contingency tables. Although in practice it is
employed when sample sizes are small, it is valid for all
sample sizes.
� 86% of those patients were not scoped
� http://research.microsoft.com/en us/um/redmond/projects/mscompbio/fisherexacttest/
Fisher Exact Test
Scope No Scope
Infection a= 10 b= 9
No Infection c= 88 d=131
Total 98 140
12/1/2014
17
Fisher Exact Test
Observed Values Expected Values
emergency no emergency Total emergency non emergency Total
infection 0 19 infection 0 19 0
non INFECTIONS 0 219 NON-EMERGENCY 0 219 0
Total 0 238 Total 0 238 0
α 0.05
df 1
χ2 #DIV/0!
p-value #DIV/0!
χ2-crit 3.841458821
sig #DIV/0!
Example: Emergency (infection & No Infection)
T-Test-Two Independent Sample Test
� T-Test- two independent sample test: A t-test helps you compare whether two
groups have different average values (for example, whether men and women have
different average heights).
Example: Age & BMI (infection/ no infections)
12/1/2014
18
AGE SUMMARY Hyp Mean Diff 0
Groups Count Mean Variance Cohen d
Infection 10 61.8 134.8
No Infection 219 53.4 298.7
Pooled 292.2 0.49183
T TEST: Equal Variances Alpha 0.05
std err t-stat df p-value t-crit lower upper sig effect r
One Tail 5.527607 1.520967 227 0.06483 1.651594 no 0.10044
Two Tail 5.527607 1.520967 227 0.12966 1.97047 -2.48468 19.29928785 no 0.10044
T Test: Two Independent Samples for
AGE
T Test: Two Independent Samples for
BMI
BMI SUMMARY
Hyp Mean
Diff 0
Groups Count Mean Variance Cohen d
Infection 12 27.4 118.3
No Infection 147 24.9 37.0
Pooled 159 42.68252 0.381046
T TEST: Equal Variances Alpha 0.05
std err t-stat df p-value t-crit lower upper sig effect r
One Tail 1.961437 1.269195 157 0.103125 1.654617 no 0.100777
Two Tail 1.961437 1.269195 157 0.20625 1.975189 -1.38476 6.363654 no 0.100777
� Jan 2014 we started to capture BMI status and since then 12 patients had infections.
12/1/2014
19
New Process
� Turn around time is days after Infection Control Committee
(as analysis is done before the meeting)
� The new process will help to rule out any problems (examples)
– Surgeon performance
– Operative arena or discharge issues
– Time to onset and organisms
– Failure of the risk model to account for patient severity (gender, age risk
score)
Challenges Remaining
• Moving the data from ICC to other
departments to motivate change
12/1/2014
20
Program Evaluations should
• Include patient data
– How many patients acquired infections
– Fewer or Less than last year
• Adjusted for volumes
• Adjusted for severity
– A quick thought point
• Include Financial Data
• Include additional or less mortality
The Source of all Knowledge is Comparative
• Compare to other facilities
– Our patients are always sicker
– The other hospital always lies
• Compare to ourselves
– Changes in our demographics and services
• Adjustable
12/1/2014
21
To look at our accomplishments (or failures) from last year
• We need last year’s CLABSI rate and this years
CLABSI rate and line days (same for CAUTI)
• Last year’s SIR and this year’s total observed
infections and total expected infections
• Last year’s HO C. difficile rate and this year’s HO C.
difficile rate and patient days.
• Last year’s MRSA hospital onset incidence
bacteremia rate and this year’s hospital onset MRSA
bacteremia rate and patient days. (same for VRE).
Get costs!
• Get a range, not one number– Pick the number in
• The middle?
• The lowest cost?
• The highest cost?
• Range?
• Know the difference between costs and charges
• We never save costs (WE AVOID THEM)
• http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf
• To update to 2014 healthcare dollars
12/1/2014
22
Want to get really fancy? Convert 2007 Healthcare dollars to 2013
healthcare dollars?• http://www.halfhill.com/inflation.html
When you hit “Options…”
You can select “U.S.
Medical Costs Inflation”
Put in 2007 for starting
year
12/1/2014
23
So $6,461 CLABSI cost in 2007 is what today?
The Patient Cost
• Find Attributable Mortality rates
– Attributable not overall mortality rates
• You may want to look at
– Attributable LOS
12/1/2014
24
Now the Math
CLABSI CAUTI Formula
• FY 2012/2013 CLABSI rate was 1.89 per 1000 line days
• This year our CLABSI rate was 1.19 (15/12571)
• If we had stayed at our old rate (1.89) we would have seen .00189 * 12571=23.76 infections. Round to 24.
• 24-15=9 So we prevented 9 infections by lowering our CLABSI rates!
12/1/2014
25
So now you just made nurses happy!
• 9 people they can see that
• But the CFO? You aren’t speaking their
language so get that attributable cost number
• $7288 * 9 = $65,592 in avoided costs or 90%
of what we pay an SD nurse a year
From Salary.com
12/1/2014
26
But the Medical Staff Committee Doesn’t Care about Dollars
• Attributable Mortality numbers ranged from
12% to 25%
• So 9 * 0.12= 1.08 or the lowered CLABSI rate
prevented 1 death
MRSA, VRE bacteremia and C diff
• Same basic formula just using patient days
rather than device days.
12/1/2014
27
SSIa little trickier
• Last year’s SIR was 1.27
• This year’s expected infections 38
• This year’s observed infections were 27
• So 1.27 * 38 =48.26 infections if the SIR had
stayed at 1.27 (rather than the 0.71 it is now)
• So 48-27 =21 SSI prevented by dropping our
rates
Infections & Costs AvoidedEstimated
• We had 21 fewer CLABSI in FY2013-20143 than we had in FY 2012-2013 (assuming FY2012-2013’s line days). These fewer infections saved UC San Diego Health Systems $542,829 and over 3 patients lives (based on published attributable mortality).
• We had 2 fewer C. difficile cases in the same time period than we had in the previous FY (assuming FY 2013-2014’s patient days). These additional infections saved UC San Diego Health Systems $16180
• We had 86 fewer CAUTI in the same time period than we had in the previous FY (assuming FY2013-2014 foleydays). These fewer infections helped UC San Diego Health System avoid an additional $71,552 in costs
12/1/2014
28
FY 2012-2013 IC Outcomes Compared to FY 2013-2014
• We had 8 more VRE bacteremias inFY2013-2014 than we had in FY 2012-2013 (assuming FY2013-2014 patient days).
• We had 7 more surgical site infections in the same time period than we had in the previous (assuming FY2013-2014 surgical volumes and acuity). These additional infections cost UC San Diego Health Systems an additional $206,101 in costs
• We had 1 additional MRSA bacteremia compared to the previous FY (assuming the FY 2013-2014 patient days) This additional case cost UC San Diego Health System an additional $3700 in costs
• Because attributable mortality rates are difficult to come by and estimated overall impact on patients lives could not be conducted.
The big picture
• For the fiscal year 93 fewer patients had
infections in the outcomes we evaluate.
• The organization avoided $420,760 in
unreimbursed treatment costs in avoiding
theses infections.
12/1/2014
29
Make the numbers “REAL”
• Example you have a daily census of 275 in
your facility and an average LOS of 3 days and
this year say a very small drop in your C. diff
rate resulting in 2 fewer healthcare associated
C diff cases for the year but still see 181 cases
for the year.
• 181 is an abstract number. I can’t think of 181
people.
But I can think of
• “We infect almost a patient every other day
with C diff”
• “On any given day in house we have two
patients here who we gave C diff during their
stay”
12/1/2014
30
Process Measures
• This same method can be used to show
reduction number of:
– IUSS
• Actionable what is being IUSS’ed
– Blood culture contaminates
• Results
– Other processes
Questions?
12/1/2014
31